Answers are grounded in this paper and cite their sources.
Background Alcohol-associated liver disease (ALD) is a significant health burden with limited therapeutic options. Neutrophil infiltration, often surrounding injured hepatocytes, is a hallmark of ALD; however, how neutrophils and hepatocytes crosstalk with each other to modulate ALD progression remains obscure. Objective We investigate the role of growth differentiation factor 15 (GDF15) in regulating hepatocyte–neutrophil interactions and its impact on ALD progression. Design Using transcriptomics, human samples and experimental mouse models, combined with single-cell transcriptomics, metabolic/biochemical assays, immune profiling, bulk RNA sequencing and rescue experiments to elucidate the underlying mechanisms and clinical relevance. Results GDF15 was predominantly expressed in hepatocytes and was elevated in both mice and patients with ALD in an endoplasmic reticulum stress-dependent manner. Genetic deletion of hepatic GDF15 exacerbated ALD, whereas hepatic GDF15 overexpression or recombinant GDF15 administration ameliorated disease severity in mice with concomitant changes in hepatic neutrophil accumulation and function. Mechanistically, GDF15 alleviates ethanol-induced hepatic steatosis, inflammation and liver injury by limiting neutrophil recruitment and activation through the ALK-5/TGF-βRII heterodimer. GDF15 also diminishes the glycolytic metabolism of neutrophils and the formation of neutrophil extracellular traps (NETs), which in turn weakens NETs-triggering metabolic reprogramming of macrophages leading to a reduced cytokine release. Pharmacological targeting of NETs alleviates the exacerbation of ALD caused by hepatocyte-specific GDF15 deficiency in terms of improved hepatic steatosis, inflammation and liver injury. Conclusion These findings identify hepatocyte-derived GDF15 as a negative regulator of pathogenic neutrophil–macrophage crosstalk during ALD progression and support its potential as a therapeutic target for mitigating neutrophil-driven liver injury.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: